AstraZeneca's Evusheld Approved In Japan For Prevention And Treatment Of SARS-CoV-2 Infection

Retrieved on: 2022-08-30 13:17:59

Tags for this article:

Medicine

Clinical medicine

Health

Prevention of HIV/AIDS

Severe acute respiratory syndrome–related coronavirus

AstraZeneca

Severe acute respiratory syndrome

Pre-exposure prophylaxis

Japan

AstraZeneca plc

AZN.L

Click the tags to see associated articles and topics

AstraZeneca's Evusheld Approved In Japan For Prevention And Treatment Of SARS-CoV-2 Infection. View article details on hiswai:

Excerpt

British drug major AstraZeneca Plc. (AZN.L, AZN) announced Tuesday that its Evusheld (tixagevimab and cilgavimab, formerly AZD7442), a long-acting ...

Article found on: www.rttnews.com

View Original Article